Vaccination Against the Tumour Associated Antigen 5T4 Induces Immune Responses in Advanced Colorectal Cancer Patients: Results Phase I/II Clinical Trial with Recombinant Modified Vaccinia Virus Ankara(TroVax)

Hawkins R., Connolly N., Harrop R., Redchenko I., Ryan M., Drury N., Kelleher M., Kingsman S., Carroll M.

DOI

10.1097/00002371-200411000-00193

Type

Conference paper

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

2004-11-01T00:00:00+00:00

Volume

27

Pages

S54 - S54

Permalink More information Close